Huijuan Song

This publication record spans a broad mix of topics including antibiotic resistance, nanoparticle-based drug delivery, cancer immunotherapy, extracellular vesicles, and hydrogel-based therapies. The work often centers on developing nanomaterials and drug-delivery platforms for cancer treatment and other conditions, alongside some studies on bacterial resistance mechanisms and patient-experience research. Given the diversity of subject matter across microbiology, oncology, materials science, and clinical/qualitative research, this may represent a shared name across multiple researchers or a very broad multidisciplinary output.

Publication output has grown from about 6 per year in 2017-2019 to a peak of 15 in 2020, with continued activity averaging around 9-13 per year through 2025, suggesting a generally steady to slightly increasing publication pace over the past decade.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026